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Abstract 
A technically simple route is described to individual epimers of side-chain derivatives of 
lanosterol (3b-hydroxy-5a-lanosta-8,24-diene). Epimerically pure 24,25-epoxy-, 24,25-
dihydroxy- and 24-bromo-25-hydroxy-lanosterol have been prepared in good yield from 
commercial (50-60%) lanosterol. Hypophosphorous acid was used as a catalyst for the 
cohalogenation of the 24(25) bond and also for the efficient conversion of 24,25-epoxy- and 
24-bromo-25-hydroxylanosterol to epimerically pure 24(R) or 24(S)-24,25-
dihydroxylanosterols.  
 
Introduction 
Side chain derivatives of lanosterol (3b-hydroxy-5a-lanosta-8,24-diene, 1a) have 
been shown to act as inhibitors of  24(25) sterol methyl transferase, which is an essential 
enzyme in the sterol biosynthesis pathway of protozoa, fungi and plants1. Because of this 
activity these compounds have potential therapeutic applications.  24,25-Epoxylanosterol is a  
2potent inhibitor of 3-hydroxy-3-methylglutaryl CoA reductase (HMG-CoA), which is a key 
regulatory enzyme in the biosynthesis of sterols in humans2. There is an association between 
incidence of cardiovascular disease and levels of serum cholesterol3, and for 
hypercholesterolemic individuals, who cannot control serum cholesterol by dietary 
modification, some other kind of intervention is indicated. For this reason there is intense 
interest in the development of inhibitors of cholesterol or sterol biosynthesis4.
Reaction of the 24(25) bond in general leads to the production of a mixture of C-24 
epimers. It is probable that, where a mixture of epimers has been used in a bioactivity 
assay5,6, the activity resides principally in one epimer and it is thus not possible accurately to 
gauge this activity. Differential bioactivity of 24(R)- and 24(S)-epoxylanosterols has been 
demonstrated7. Early reports of the separation of  the epimers of 24,25-epoxylanosterol 
acetate by crystallization8 have not been amenable to emulation more recently7,9 and instead 
separation of the isomers was achieved by repetitive HPLC. No other separations of epimeric 
C-24 derivatives of lanosterol have been reported. 
We here report a technically simple method for the production of individual C-24 
epimers of lanosterol derivatives in high yield from commercial (50-60%) lanosterol, without 
recourse to highly toxic reagents, or tedious chromatography. 
 
Experimental Procedure 
Materials: Lanosterol (50-60%) was purchased from Sigma and used without any further 
purification. Hypophosphorous acid (50 wt.% in water) and all other reagents were purchased 
from Aldrich. 
General Methods: Column chromatography was carried out on Merck silica gel (70-230 
mesh) using the eluants indicated.  TLC was carried out using Alugram® Sil G/UV254 plates.  
3Elemental analysis was carried out by the Chemistry Department of the University of Otago, 
New Zealand.  All melting points were obtained on a Reichert-Jung micro-melting point 
determination apparatus and are uncorrected. Optical rotations were measured on a Ramsey 
AA-5 polarimeter. IR spectra were obtained using a Perkin Elmer M-1600 IR 
spectrophotometer. Compounds described as epimerically pure were ~97% based on NMR 
methods. 
Gas Chromatography: Gas chromatography with flame ionization detection (GC-FID) was 
carried out using a Hewlett-Packard Ultra 2 (25m x 0.33mm) cross-linked phenyl methyl 
silicone fused silica capillary column. Conditions used were 55°C(1 min), 30°C min-1 to 
200°C, 4°C min-1 to 320°C. 
Nuclear Magnetic Resonance Spectrometry (NMR): NMR spectra were obtained using a 
Bruker ADV DRX 400 MHz spectrometer, in chloroform-d1 and referenced to chloroform. 
1H, 13C, DEPT135, H,H-Cosy, HSQC, HMBC and NOE difference experiments were carried 
out. For HSQC a J value of 147 Hz was used and for HMBC a delay value of 65 ms was used 
for evolution of long range couplings. 
X-ray crystallography: X-ray data were obtained with a Bruker CCD diffractometer using 
Mo-K X-rays (=0.71073Å).  Data were corrected for absorption and other effects using an 
empirical method (SADABS)10 and the structures were solved and refined (based on Fo2)
using the SHELX programs11. All hydrogen atoms were included in calculated positions 
using a riding model. Absolute configuration was determined X-ray crystallographically from 
the anomolous dispersion for the hydroxy-bromides, and by reference to the known 
configuration of the main skeleton for the epoxide and diol. Full details of the structures have 
been lodged with the Cambridge Crystallographic Database, CCDC No XXXXXXX. 
 
4Acetylation of Lanosterol: To a solution of commercial lanosterol (a mixture of 1a and 2a,
Scheme 1) (80 g, 0.187 mol, 50-60% pure), dimethylaminopyridine5,12 (1.6 g, 0.013mol) and 
pyridine (120 mL) in CH2Cl2 (700 mL) was added acetic anhydride (30 mL) and the resulting 
solution was stirred (6h) at room temperature.  The reaction mixture was poured into 300 mL 
of CH2Cl2 and washed successively with 5% HCl, 10% aqueous NaHCO3 and water.  After 
evaporation of the CH2Cl2 in vacuo, the residue was recrystallized from acetone/methanol to 
afford a mixture of  lanosterol acetate, 3-acetoxy-5-lanosta-8,24-diene  (1b) and 
dihydrolanosterol acetate (2b) as a colourless solid (72 g), mp 125-129°C (Lit.13 125-130°C). 
GC-FID indicates the product is ca 61:39 of 1b:2b.
24(R)-3-acetoxy-24,25-epoxy-5-lanost-8-ene, (3bR), and 24(S)-3-acetoxy-24,25-
epoxy-5-lanost-8-ene, (3bS): To a solution of the impure lanosterol acetate from above (1b
and 2b) (20 g, 0.028 mol) in dichloromethane (600 mL) a mixture of m-chloroperbenzoic acid 
(70%, 6.5 g, 0.03 mol) and sodium hydrogen carbonate (2.2 g, 0.05 mol) was added in the 
following manner: half was added at room temperature over 3 hours and the remainder at 0ºC 
(ice bath), also over 3 hours.  The mixture was stirred vigorously (1 hour) and left in a 
refrigerator overnight.  The mixture was washed with water, dried (MgSO4) and after 
evaporation of the solvent the crude residue was purified by flash column chromatography 
(50% dichloromethane in light petroleum) giving unreacted dihydrolanosterol acetate (2b)
(7.4 g, 96% recovery) as a colourless solid.  Further elution with dichloromethane afforded 
24(R,S)-3-acetoxy-24,25-epoxy-5-lanost-8-ene, (3b) as a colourless solid (10.8g, 85% 
based on 1b used), mp 172-180ºC.  The mixed epoxides were crystallized from hexane (30 
5mL) at room temperature to give 24(R)-3-acetoxy-24,25-epoxy-5-lanost-8-ene, 3bR (5.4 
g). This  product was recrystallised twice from acetone to give pure 3bR ( 3.9 g) mp 194-
196°C (Lit8,9 194-197°C or 194-195.5°C) ; []D20 +63.7° (c1.6, CHCl3); (Found: C, 79.06; H, 
10.57.  C32H52O3 requires C, 79.35; H, 10.73%). The filtrate from the first crystallisation was 
evaporated and the residue containing crude 24(S)-3-acetoxy-24,25-epoxy-5-lanost-8-ene, 
3bS, (5.2 g) was purified by fractional crystallization from hexane and recrystallization from 
acetonitrile which afforded pure 3bS (3.6 g), mp 137-139°C (Lit.8,9 137-139°C or 140-
141.5°C); []D20 +56.22° (c1.6,CHCl3); (Found: C, 79.22; H, 10.66%. C32H52O3 requires C, 
79.35; H, 10.73%). The absolute configurations of 3bR and 3bS were determined by X-ray 
crystallography of 3bR.
24(R)-3-hydroxy-24,25-epoxy-5-lanost-8-ene (3aR ) and 24(S)-3-hydroxy-24,25-
epoxy-5-lanost-8-ene (3aS): The acetate 3bS (1.2 g, 2.1 mmol) was treated with dry 
ethanolic 10% KOH with stirring at 60°C for 2 hours.  Precipitation with water, extraction 
into ether and crystallization from hexane/ethyl acetate afforded stereochemically pure 24(S)-
3-hydroxy-24,25-epoxy-5-lanost-8-ene, 3aS (0.86 g, 92%), mp123-124°C (Lit.7 120-
123°C); []D20 +51.2 ( c 1.6, CHCl3);  (Found: C, 81.21; H, 11.33%.  C30H50O2 requires C, 
81.46; H, 11.30%). Similar treatment of 3bR (1.2 g, 2.1 mmol) afforded  stereochemically 
pure  24(R)-3-hydroxy-24,25-epoxy-5-lanost-8-ene 3aR (0.83 g, 89%), mp 130-131°C
(Lit.7,8 131-134°C); []D +67.5 ( c 1.6, CHCI3).   (Found: C, 81.19; H, 11.13%. C30H50O2
requires C, 81.46; H, 11.30%).  
Conversion of the epoxy acetates, 3bR and 3bS, to the corresponding diols, 4bR and 
4bS: To a solution of the epoxy acetate, 3bS (5.0 g, 0.01 mol) in 2-propanol (125 mL) was 
added water (50 mL) and hypophosphorous acid (9 mL, 50% in water).  The mixture was 
6heated to reflux (3h), diluted with water, filtered and washed. After drying, the residue was 
purified by column chromatography (CH2Cl2:EtOAc, 2:1) to afford 4bS (4.82 g, 93%), mp 
176-177°C; []D20 +26.2 (c 1.6, CHCl3); max(KBr)/cm-1 3540, 3410, 1723, 1468, 1371, 1259, 
1164. (Found: C, 76.32; H, 10.75%. C32H54O4 requires C, 76.44; H, 10.83%).   
Similar treatment of 3bR afforded 4bR (4.92 g, 95%), mp 186-187°C; []D20 +40.0 (c 1.6, 
CHCl3); max(KBr)/cm-1 3540, 3410, 1723, 1468, 1372, 1257, 1162. (Found: C, 76.10; H, 
10.76%. C32H54O4 requires C, 76.44; H, 10.83%). The absolute configurations at C-24 of 4bR
and 4bS were confirmed by X-ray crystallography on crystals of the S epimer. 
 
24(R)-3-acetoxy-24-bromo-25-hydroxy-5-lanost-8-ene (5bR) and 24(S)-3-acetoxy-24-
bromo-25-hydroxy-5-lanost-8-ene (5bS) : To a solution of lanosterol acetate (1b) (10 g, 
61% 1b, 0.014 mol) in acetone (900 mL), water (15 mL) and hypophosphorous acid (2.7 mL, 
50% aqueous) was added N-bromosuccinimide (3.04 g, 0.017 mol).  The reaction mixture 
was stirred at room temperature (5 min) and diluted with water.  The product was extracted 
into ether, washed thoroughly with saturated aqueous sodium thiosulphate, dried (MgSO4)
and evaporated under reduced pressure to give a crude mixture of unreacted dihydrolanosterol 
acetate (2b) and 24(R,S)-3-acetoxy-24-bromo-25-hydroxy-5-lanost-8-ene (5b) (11.7 g), 
which was fractionated by flash column chromatography.  Elution with hexane/ether (5:1) 
gave dihydrolanosterol acetate (2b) (3.7 g, 95% recovery) with a minor by-product.  Further 
elution with hexane/ether gave 5b (5.12 g, 84%).  
Two-fold recrystallisation from hexane (60 mL) afforded crude 24(S)-3-acetoxy-24-bromo-
25-hydroxy-5-lanost-8-ene ( 5bS, 2.52 g).  This crude product was recrystallized twice from 
hexane to give pure 5bS ( 2.1 g), mp 163-165°C; []D20 +23.1° (c1.6, CHCl3). (Found: C, 
768.14; H, 9.21; Br,14.20%. C32H53O3Br requires C, 68.00; H, 9.38; Br,14.14%). The 
configuration at C-24 was assigned by X-ray crystallography of both a monoclinic and an 
orthorhombic polymorph.  
The combined filtrates from the first recrystallisations were evaporated under reduced 
pressure and purified by fractional crystallization from hexane followed by two-fold 
crystallization from hexane/methyl acetate to afford 24(R)-3-acetoxy-24-bromo-25-hydroxy-
5-lanost-8-ene (5bR, 2.1 g), mp 157-159°C; []D20 +66.8° (c1.6, CHCl3). (Found: C, 68.28; 
H, 9.64; Br,14.01%. C32H53O3Br requires C, 68.00; H, 9.38; Br,14.14%). This form was also 
fully characterised by an X-ray structure determination. 
Conversion of hydroxybromides, 5bS and 5bR, to the corresponding diols, 4bR and 4bS:
A solution of 5bS (2.0 g, 3.5 mmol) in dry 2-propanol (100 mL) and anhydrous potassium 
acetate (1.0 g, 10.2 mmol) was heated under reflux (2h).  The reaction mixture was diluted 
with hot water (6 mL), hypophosphorous acid (60 µL, 50% in water) was added and the 
mixture further refluxed (2h).  The reaction mixture was cooled, diluted with water and 
extracted into EtOAc.  The EtOAc solution was washed successively with water, NaHCO3
(5%) and saturated NaCl solution and then dried and evaporated to a white residue.  Column 
chromatography (CH2Cl2:EtOAc, 2:1) afforded 4bR (1.48 g, 84%), identified by NMR 
spectroscopy.  
Similar treatment of  5bR afforded 4bS (1.43g, 81%). 
 
X-ray crystallography:
Structure of the R-epoxide, 3bR: Crystal data: C32H52O3, M = 484.74, orthorhombic, a = 
10.6022(1), b = 36.3388(3), c = 7.4573(1) Å, U 2873.08(5) Å3, T -123°C, space group 
P212121, Z = 4, F(000) = 1072, µ(Mo-K) = 0.069 mm-1, 16833 reflections collected, 5810 
8unique (Rint 0.0271) in the range 1°< 	 < 26.5°, corrected for absorption (Tmax, min 0.993, 
0.973). Crystal dimensions 0.40 x 0.38 x 0.10 mm3. Refinement gave R1 0.0473 [5076 data 
with I > 2
 (I)] and wR2 0.1192 (all data), GoF 1.153.  
Structure of the S-diol, 4bS: Crystal data: C32H54O4, M 502.75, orthorhombic, a = 
6.0576(4), b = 9.5444(6), c = 50.937(3) Å, U = 2945.0(3) Å3, T 164 K, space group P212121,
Z = 4, F(000) 1112, µ(Mo-K) 0.07 mm-1, 17278 reflections collected, 5906 unique (Rint 
0.0303), in the range 1.5° < 2	 < 26.2°, corrected for absorption (Tmax,min 0.982, 0.978).  
Crystal dimensions 0.32 x 0.30 x 0.26 mm3. Refinement gave R1 0.0474 [I > 2
 (I) data] and 
wR2 0.1218 (all data), GoF 1.076.  
Structure of the S-hydroxy bromide, 5bS (monoclinic form): Crystal data: C32H53O3Br, M = 
565.65, monoclinic, a = 7.4488(1), b = 19.5340(1), c = 20.8918(3) Å,  = 91.287(1)°, U
3039.09(6) Å3, T -123°C, space group P21, Z = 4, F(000) = 1216, µ(Mo-K) = 1.38 mm-1,
18108 reflections collected, 10970 unique (Rint 0.0179) in the range 1°< 	 < 26.5°, corrected 
for absorption (Tmax, min 0.643, 0.424). Crystal dimensions 0.75 x 0.40 x 0.35 mm3.
Refinement gave R1 0.0272 [9979 data with I > 2
 (I)] and wR2 0.0658 (all data), GoF 1.011, 
absolute structure Flack x parameter 0.004(4). 
Structure of the S-hydroxy bromide, 5bS (orthorhombic form): Crystal data: C32H53O3Br, M 
= 565.65, orthorhombic, a = 7.5434(1), b = 11.4508(2), c = 35.3936(5) Å, U 3057.23(8) Å3, T
-123°C, space group P212121, Z = 4, F(000) = 1216, µ(Mo-K) = 1.37 mm-1, 17512
reflections collected, 5752 unique (Rint 0.0284) in the range 1°< 	 < 25.5°, corrected for 
absorption (Tmax, min 0.885, 0.578). Crystal dimensions 0.72 x 0.40 x 0.12 mm3. Refinement 
gave R1 0.0304 [5300 data with I > 2
 (I)] and wR2 0.0763 (all data), GoF 1.048, absolute 
structure Flack x parameter 0.022(6). 
9Structure of the R-hydroxy bromide, 5bR: Crystal data: C32H53O3Br, M = 565.65, 
monoclinic, a = 12.7619(1), b = 6.7924(1), c = 17.3796(1) Å,  = 101.73(1)°, U 1475.06(3) 
Å3, T -123°C, space group P21, Z = 2, F(000) = 608, µ(Mo-K) = 1.42 mm-1, 8721 
reflections collected, 5292 unique (Rint 0.0266) in the range 1.5°< 	 < 26.5°, corrected for 
absorption (Tmax, min 0.919, 0.458). Crystal dimensions 0.65 x 0.08 x 0.06 mm3. Refinement 
gave R1 0.0341 [4565 data with I > 2
 (I)] and wR2 0.0667 (all data), GoF 0.953, absolute 
structure Flack x parameter 0.019(6). 
Results and Discussion 
Epoxidation of acetylated commercial lanosterol (mixture of 1b and 2b in the approximate 
ratio 61:39) afforded a mixture of the epimeric 24,25-epoxylanosterol acetates (3bR and 3bS)
(Scheme 1).  After column chromatography to remove 2b, the epoxides were separated by 
fractional crystallization from hexane, making use of the much higher solubility of the S
epoxide in hexane.  This procedure was based on one previously reported8 but the separation 
method has been improved, since the earlier one was apparently not reproducible7,9. (A 
similar method has been applied very recently for obtaining pure samples of 2b, but the 
epoxides were not further separated10). The individual epimeric acetates 3bR and 3b (and the 
de-acetylated alcohols 3aR and 3aS) were characterized by NMR. Only the signals for the 
side chain atoms are reported in Table 1, with the full carbon and proton chemical shifts of 
the acetates and corresponding free sterols listed in Supplementary Tables 1 - 3 respectively 
since they match literature values, where they are available14.
The earlier study8 deduced the absolute stereochemistry of the epoxides by chemical 
methods via reduction to the corresponding 24-OH species, and we have now confirmed the 
assignment by an X-ray crystal structure determination (See Fig 1a for the conformation of 
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the side-chain of 3bR).  For these epoxides, the separate epimers are best identified by their 
melting points and by their optical rotation, because there are insufficient differences in the 
1H NMR spectra for reliable discrimination, and the 13C spectra can only just distinguish 
them9.
The epoxides are useful materials for preparing new derivatives. Upon refluxing in 2-
propanol with aqueous hypophosphorous acid, 3bR and 3bS afforded the corresponding 
epimers of the new diols, 24,25-dihydroxylanosterol acetate, 4bR and 4bS respectively, in 
excellent yield (Scheme 1). 2-Propanol was the solvent of choice to afford miscibility with 
water without competing as a nucleophile and thereby forming unwanted ethers, which arose 
if methanol or ethanol was used instead. It was reported earlier that water-soluble organo-
halides could be reduced in high yields using hypophosphorous acid, AIBNA and NaHCO3 in 
water 15 but there appears to be no precedent for use of hypophosphorous acid for the 
synthesis of vicinal diols from epoxides.  This acid appears to as efficient (and as free from 
by-products) for the opening of the epoxides as the more more usual perchloric acid16,
without the associated hazards of the latter. 
The diols 4bR and 4bS were fully characterized. Selected side-chain carbon and 
proton NMR chemical shifts are reported in Tables 1 and 2 respectively, with full 
assignments in the Supplementary information.  In this case, the epimers could be clearly 
distinguished, and the epimeric purity assessed, by the 1H signals from the protons on C-24.  
For the R epimer this appears as a pseudo triplet at  3.32 (apparent J = ca 6 Hz), while the 
equivalent S is an apparent doublet (J = 10 Hz) at  3.26.
The high yield and the retention of configuration on going from the epoxide to the diol 
indicates that the reaction proceeds by the predicted16 nucleophilic attack upon C-25 under 
these acidic conditions.   
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The assignment of configuration for the diols 4b was confirmed by an X-ray crystal 
structure determination on 4bS, the side-chain being that illustrated in Fig 1b. Interestingly 
the R and S diol epimers form isomorphous crystals, with one very long (51 Å) axis so cannot 
be distinguished on the basis of unit cell and space-group measurements. Because of this they 
tend to co-crystallise so epimerically-impure samples cannot be readily purified by 
recrystallisation. 
An alternative route for epimeric separation of lanosterol side-chain species was 
developed using novel hydroxy-bromide derivatives. Thus treatment of acetylated 
commercial lanosterol with N-bromosuccinimide in acetone, water and in the presence of a 
catalytic amount of hypophosphorous acid, (Scheme 1), afforded the epimeric 24-bromo-25-
hydroxylanosterol acetates (5bR and 5bS), which were separated from unreacted 2b, by flash 
column chromatography and from each other by crystallisation. It is significant that this 
procedure gives only 24-Br, 25-OH derivatives regiospecifically, whereas mixtures of 
isomers are more normally obtained. Solvent choice is critical since the same reaction in 
CH2Cl2 lacks this specificity. 
 In the NMR spectra of 5bR and 5bS the 1H patterns are again sufficiently different to 
distinguish the epimeric forms, through the signals of the protons attached to C-22, C-23 and 
C24 (see Table 2). The absolute configuration of C-24 was assigned for both epimers by X-
ray crystallography. The structures of the side-chains of 5bR and 5bS are shown in Figures 1c 
and 1d.  
The hydroxy-bromides, 5b, could also be converted to the diols, 4b, using a one-pot 
procedure. When the (S)-hydroxybromide 5bS was used as the starting material the (R)-diol 
4bR resulted, showing inversion of configuration at C-24 with high stereospecificity .  This 
can be rationalised assuming there is initial conversion of 5bS to the epoxide 3bR with 
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inversion of configuration and subsequent in situ conversion to the diol with retention of 
configuration. 
The crystal structure determinations were carried out to provide unambiguous 
correlation between absolute configuration and physical properties. For the most part the 
structures were unremarkable. The epoxide 3bR packs in the crystal with only weak C-H...O 
interactions, as expected.  All of the others have structures that are controlled by hydrogen-
bonding interactions. The diol 4bS forms chains of molecules linked by hydrogen-bonding 
from O(3)-H...O(4')-H, with the arrangement of molecules such that the opposite 
configuration at C-24 can be accommodated with little rearrangment, which explains the 
isomorphism/ co-crystallisation of the two forms. For the S-hydroxy-bromide 5bS there are 
two crystal polymorphs.  The monoclinic form has two independent molecules which are 
linked as H-bonded trimers -O(3)-H...O(3')-H...O(12'')=C<, whereas the orthorhombic form 
has simpler packing involving linear chains of molecules packed head-to-tail with O(3)-
H...O(12')=C< interactions. For the R-hydroxybromide 5bR the same O(3)-H...O(12')=C< 
link is used but the molecules are now stacked side-to-side to generate a zig-zag chain. 
Conclusion. 
In conclusion, we report here (i) an improved route to separated epimers of the 25, 25-
epoxide of lanosterol; (ii) the conversion of the R and S epoxides to the corresponding 24, 25-
diols with retention of configuration; (iii) a route to the pure epimers of novel 24-Br, 25-OH 
derivatives of lanosterol; and (iv) conversion of the R and S bromo-hydroxides to the S and R 
diols respectively.  In each case the transformation and separation of the epimers are 
experimentally straightforward with good yields. This work also establishes a new procedure 
using hypophosphorous acid as an efficient reagent for regioselective hydroxy-bromination of 
olefins, and for ring-opening reactions of epoxides. 
13
The absolute configurations were established unambiguously via X-ray structure 
determinations. These species should prove to be useful for preparing other epimerically pure 
side-chain compounds for biological use.  
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Captions to Figures
Figure 1. The conformations of the side chains for the structures of: (a) the R-epoxide 3bR;
(b) the S-diol 4bS; (c) the S-hydroxybromide 5bS (in the orthorhombic form); and 
(d) the R-hydroxybromide 5bR.
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Table 1 13C and 1H NMR Assignments of Side-chains of Acetates of Lanosterol Derivatives 
 
C 3bR 3bS 4bR 4bS 5bR 5bS
Carbon Chemical Shift (ppm) 
20 36.27 36.4 36.6 37.06 35.84 36.87 
21 18.72 18.62 18.86 19.14 18.71 19.42 
22 32.64 32.84 33.45 33.9 35.39 36.01 
23 25.67 25.97 28.73 29.03 31.03 31.63 
24 64.85 65.00 79.05 79.22 72.5 73.41 
25 58.49 58.20 73.45 73.50 72.88 72.94 
26 24.99 25.01 26.85 26.82 27.09 27.01 
27 18.80 18.70 23.61 23.53 26.11 26.16 
28 27.95 27.96 28.22 28.22 28.23 28.23 
 Proton Chemical Shift (ppm), Coupling constants (Hz), NOE Enhancement (%) 
20 1.42 1.45 1.40 1.36 1.40 1.41 
21 0.91 
J21,20=6.2Hz 
0.91 
J21,20=5.7Hz 
0.89  
J21,20=6.1Hz 
0.89  
J21,20=6.3 Hz 
0.90 
J21,20=5.7Hz 
0.92 
J21,20=6.3Hz 
22 1.20, 1.51 1.61, 1.10 1.47, 1.26 0.95, 1.73 1.40, 1.52 1.05, 1.88 
23 1.39, 1.65 1.46, 1.58 1.36 1.10, 1.52 1.79 1.58, 1.99 
24 2.69 (6.2 & 
6.2Hz) 
2.69 (6.1& 
6.1Hz) 
3.32 (6.1 & 
6.1Hz) 
3.26 (2.0 & 
10.0 Hz) 
4.00 (3.8& 
9.7Hz) 
3.95 (1.8& 
11.1Hz) 
26a 1.30 (6%) 1.30 (5%) 1.19 (2%) 1.19 (5%) 1.36(3%) 1.35 (2.3%) 
27 1.26 (0%) 1.26 (0%) 1.14 (0%) 1.13 (0%) 1.33 (1.8%) 1.33 (1.8%) 
28 0.88 0.88 0.86 0.86 0.88 0.88 
29 0.88 0.88 0.86 0.86 0.88 0.88 
30 0.87 0.87 0.86 0.86 0.88 0.88 
a Assigned on the basis that it displayed the largest NOE enhancement upon irradiation of H-24 (given in 
parenthesis). 
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Supplementary Table 1: 
 13C NMR Spectra of Side-chain Derivatives of Lanosterol Acetate  
C 3bR 3bS 4bR 4bS 5bR 5bS
1 35.30 35.30 35.60 35.60 35.61 35.61 
2 24.21 24.21 24.49 24.48 24.50 24.50 
3 80.97 80.98 81.29 81.29 81.24 81.25 
4 37.85 37.85 38.12 38.12 38.14 38.13 
5 50.52 50.53 50.83 50.79 50.85 50.85 
6 18.16 18.16 18.44 18.44 18.45 18.44 
7 26.42 26.42 26.70 26.70 26.72 26.71 
8 134.46 134.46 134.79 134.80 134.80 134.78 
9 134.31 134.31 134.60 134.60 134.63 134.63 
10 36.93 36.93 37.22 37.22 37.24 37.24 
11 21.03 21.03 21.31 21.32 21.32 21.31 
12 30.98 31.00 31.33 31.33 31.33 31.30 
13 44.53 44.52 44.84 44.82 44.87 44.85 
14 49.86 49.85 50.15 50.12 50.18 50.14 
15 30.84 30.84 31.12 31.12 31.12 31.12 
16 28.29 28.24 28.59 28.48 28.54 28.45 
17 50.31 50.41 50.91 50.83 50.74 50.73 
18 15.81 15.81 16.11 16.11 16.13 16.10 
19 19.24 19.24 19.49 19.49 19.51 19.50 
20 36.27 36.40 36.60 37.06 35.84 36.87 
21 18.72 18.62 18.86 19.14 18.71 19.42 
22 32.64 32.84 33.45 33.9 35.39 36.01 
23 25.67 25.97 28.73 29.03 31.03 31.63 
24 64.85 65.00 79.05 79.22 72.50 73.41 
25 58.49 58.20 73.45 73.50 72.88 72.94 
26 24.99 25.01 26.85 26.82 27.09 27.01 
27 18.80 18.70 23.61 23.53 26.11 26.16 
28 27.95 27.96 28.22 28.22 28.23 28.23 
20
CH3(acetyl) 21.40 21.40 21.60 21.60 21.61 21.61 
CO (acetyl) 171.1 171.11 171.34 171.34 171.27 171.28 
29 16.59 16.56 16.83 16.83 16.84 16.84 
30 24.29 24.28 24.57 24.57 24.57 24.57 
Supplementary Table 2 
1H NMR Spectra of Lanosterol Acetate Side-chain Derivatives  
C 3bR 3bS 4bR 4bS 5bR 5bS
1 1.32, 1.73 1.31, 1.73 1.29 , 1.70 1.26, 1.68 1.31", 1.73$ 1.30", 1.73$
2 1.62, 1.70 1.62, 1.66 1.61, 1.66  1.56, 1.64 1.63$, 1.69" 1.60$, 1.70"
3 4.49 (11.5 & 
4.5Hz) 
4.49 (11.5& 4.5Hz) 4.48  (11.5& 4.5Hz) 4.48  (11.5& 4.5Hz) 4.50  (11.6& 
4.5Hz) 
4.50 (11.5& 4.5Hz) 
5 1.14 1.14 1.14 1.10 1.13 1.15 
6 1.55, 1.67 1.51, 1.65 1.49, 1.65 1.46, 1.62 1.52", 1.67$ 1.51", 1.67$
7 2.05 2.04 2.02 1.99 2.04 2.04 
11 2.04 2.03 1.99 1.96 2.03 2.03 
12 1.70, 1.80 1.72, 1.76 1.68, 1.73 1.65, 1.70 1.69, 1.74 1.69, 1.74 
15 1.17, 1.59 1.17, 1.60 1.16, 1.57 1.13, 1.54 1.19", 1.60$ 1.19", 1.60$
16 1.32, 1.93 1.34, 1.93 1.94, 1.35 1.31, 1.89 1.34$, 1.97" 1.37$, 1.94"
17 1.50 1.49 1.48 1.45 1.50 1.49 
18 0.69 0.69 0.68 0.67 0.70 0.69 
19 1.00 1.00 0.99 0.99 1.00 1.00 
20 1.42 1.45 1.40 1.36 1.40 1.41 
21 0.911 J21,20=6.2Hz 0.91 J21,20=5.7Hz 0.89  J21,20=6.1Hz 0.90  J21,20=6.3 Hz 0.90 J21,20=5.7Hz 0.92 J21,20=6.3Hz 
22 1.20, 1.51 1.61, 1.10 1.47, 1.26 0.95, 1.73 1.40, 1.52 1.05, 1.88 
23 1.39, 1.65 1.46, 1.58 1.36 1.10, 1.52 1.79 1.58, 1.99 
24 2.69 (6.2&6.2Hz) 2.69 (6.1&6.1Hz) 3.32 (6.1&6.1Hz) 3.26 (2.0&10.0 Hz) 4.00 (3.8& 9.7Hz) 3.95 (1.8& 11.1Hz) 
26a 1.30 (6%) 1.30 (5%) 1.19 (2%) 1.19 (5%) 1.36(3%) 1.36(2.3%) 
27 1.26(0%) 1.26 (0%) 1.14 (0%) 1.14 (0%) 1.33(1.8%) 1.33(1.8%) 
28 0.88 0.88 0.86 0.86 0.88 0.88 
CH3b 2.05 2.05 2.03 2.02 2.04 2.04 
29 0.88 0.88 0.86 0.86 0.88 0.88 
30 0.87 0.87 0.86 0.86 0.88 0.88 
a Assigned on the basis that it displayed the largest NOE enhancement upon irradiation of H-24(given in parenthesis). 
b 3-O-acetyl group 
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Supplementary Table 3 
13C and 1H NMR Chemical Shifts of 24(R)- and 24(S),25-epoxy-5--lanost-8-en-3--ol. 
 
3aR 3aS
C C H C H
1 35.65 1.23, 1.73 35.65 1.23, 1.73
2 27.91 1.55, 1.65 27.91 1.58, 1.65
3 79.02 3.22 (4.5 & 11.5 Hz) 79.02 3.23 (4.8 & 11.5Hz) 
4 38.94 - 38.94 - 
5 50.48 1.04 50.48 1.05 
6 18.30 1.50, 1.68 18.30 1.50, 1.68
7 26.55 2.03 26.55 2.04 
8 134.42 - 134.41 - 
9 134.52 - 134.52 - 
10 37.08 - 37.09 - 
11 21.04 2.01 21.04 2.02 
12 31.04 1.67, 1.73 31.06 1.67, 1.75 
13 44.57 - 44.57 - 
14 49.88 - 49.87 - 
15 30.87 1.18, 1.60 30.87 1.18, 1.60
16 28.27 1.33, 1.93 28.23 1.35, 1.93
17 50.35 1.49 50.45 1.48 
18 15.81 0.70 15.81 0.70 
19 19.18 0.98 19.18 0.98 
20 36.26 1.43 36.37 1.46 
21 18.71 0.91  J21,20=6.1Hz 18.62 0.91 J21,20=6.0Hz 
22 32.67 1.22, 1.52 32.86 1.09,1.61 
23 25.67 1.39, 1.61 25.95 1.45, 1.55 
24 64.82 2.70 (6.2&6.2Hz) 64.96 2.68 (6.0&6.0Hz) 
25 58.42 - 58.12 - 
26 24.96 1.30 24.97 1.30 
27 18.78 1.26 18.68 1.26 
28 28.00 1.00 28.00 1.00 
22
29 15.44 0.81 15.44 0.81 
30 24.28 0.88 24.28 0.88 
